These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6871339)

  • 21. [Grouped Cox regression model and its application in study of prognostic factors on cancer].
    Xiang Y; Gao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):46-50. PubMed ID: 8082141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bootstrap analysis of multivariate failure time data.
    Monaco J; Cai J; Grizzle J
    Stat Med; 2005 Nov; 24(22):3387-400. PubMed ID: 16237657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease.
    Bangalore S; Gopinath D; Yao SS; Chaudhry FA
    J Am Soc Echocardiogr; 2007 Mar; 20(3):244-52. PubMed ID: 17336749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An efficient alternative to the stratified Cox model analysis.
    Mehrotra DV; Su SC; Li X
    Stat Med; 2012 Jul; 31(17):1849-56. PubMed ID: 22437375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative efficiency of Zelen's prerandomization design for clinical trials.
    Anbar D
    Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of survival data with cross-effects of survival functions.
    Bagdonavicius V; Hafdi MA; Nikulin M
    Biostatistics; 2004 Jul; 5(3):415-25. PubMed ID: 15208203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing interactions of binary time-dependent covariates with time in cox proportional hazards regression models using cubic spline functions.
    Heinzl H; Kaider A; Zlabinger G
    Stat Med; 1996 Dec; 15(23):2589-601. PubMed ID: 8961465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of cumulative incidence function under the proportional hazards model.
    Cheng SC; Fine JP; Wei LJ
    Biometrics; 1998 Mar; 54(1):219-28. PubMed ID: 9544517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyzing biological rhythms in clinical trials.
    Elkum NB; Myles JD; Kumar P
    Contemp Clin Trials; 2008 Sep; 29(5):720-6. PubMed ID: 18571991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian analysis of proportional hazards models built from monotone functions.
    Gelfand AE; Mallick BK
    Biometrics; 1995 Sep; 51(3):843-52. PubMed ID: 7548703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specification test for univariate and multivariate proportional hazards models.
    Crouchley R; Pickles A
    Biometrics; 1993 Dec; 49(4):1067-76. PubMed ID: 8117901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Historical controls, data banks, and randomized trials in clinical research: a review.
    Fleming TR
    Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214
    [No Abstract]   [Full Text] [Related]  

  • 36. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametric models for accelerated and long-term survival: a comment on proportional hazards.
    Frankel P; Longmate J
    Stat Med; 2002 Nov; 21(21):3279-89. PubMed ID: 12375304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome measures for early phase clinical trials.
    Gordon PH; Cheng B; Montes J; Doorish C; Albert SM; Mitsumoto H
    Amyotroph Lateral Scler; 2007 Oct; 8(5):270-3. PubMed ID: 17852017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.